ADULT VACCINES 2023-2024
No current value reported
| Recipient | MERCK SHARP & DOHME LLC UEI FCFDA78HKKG2 |
|---|---|
| Award ID | 75D30123D16729 |
| Award amount | No current value reported |
| Award type | — |
| Awarding agency | Department of Health and Human Services — Centers for Disease Control and Prevention |
| NAICS | 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING |
| PSC | 6505 |
| Set-aside | Unrestricted |
| Start date | Jul 1, 2023 |
| End date | — |
| Place of performance | — |
| Record updated | Aug 30, 2023 |
View the official award record
More awards won by MERCK SHARP & DOHME LLC
COVID-19 ORAL ANTIVIRAL MK-4482 (MOLNUPIRAVIR)
Department of Defense · $2,205,000,834 · Jun 7, 2021
IGF::OT::IGF
Department of Health and Human Services · $236,307,634 · Sep 28, 2017
ERVEBO PROCUREMENT
Department of Health and Human Services · $156,033,983 · Sep 30, 2024
ADDRESSING THE COVID-19 PANDEMIC: URGENT PRIORITIES
Department of Health and Human Services · $102,299,549 · Mar 1, 2021
BPS - ADVANCE THE DEVELOPMENT OF V920, A VACCINE AGAINST EBOLA VIRUS USING A RECOMBINANT VESICULAR STOMATITIS VIRUS VECTOR. IGF::OT::IGF
Department of Health and Human Services · $65,103,309 · Aug 29, 2016
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids